HIV/AIDS Dietary Supplement Research Sponsored By NCCAM, NINR
This article was originally published in The Tan Sheet
Executive Summary
NCCAM is looking to fund research on the properties of botanicals used by HIV/AIDS patients, including their potential antiretroviral properties as well as their ability to alleviate the side effects of HIV/AIDS drugs or to interact with such drugs
You may also be interested in...
Protocol Review, Clinical Trial Conduct Purview Of New NCCAM Office
NCCAM's Office of Clinical & Regulatory Affairs expects to use an FDA draft guidance on botanical drug products as a starting point for reviewing research protocols and overseeing clinical trials funded by the center, OCRA Director Jonathan Berman, MD/PhD, said Aug. 26
Protocol Review, Clinical Trial Conduct Purview Of New NCCAM Office
NCCAM's Office of Clinical & Regulatory Affairs expects to use an FDA draft guidance on botanical drug products as a starting point for reviewing research protocols and overseeing clinical trials funded by the center, OCRA Director Jonathan Berman, MD/PhD, said Aug. 26
Protocol Review, Clinical Trial Conduct Purview Of New NCCAM Office
NCCAM's Office of Clinical & Regulatory Affairs expects to use an FDA draft guidance on botanical drug products as a starting point for reviewing research protocols and overseeing clinical trials funded by the center, OCRA Director Jonathan Berman, MD/PhD, said Aug. 26